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Abstract
Background: We investigated the ways in which research evidence about the health effects from
secondhand smoke (SHS) and smokefree policies was publicly used or regarded by New Zealand
parliamentary politicians, during efforts to strengthen a smokefree law (ie, from 1997 to 2005).
Methods: A documentary case study used published and unpublished material recording the use
of research evidence by politicians. The material was collected for the period 1997–2005 from the
parliamentary record, media and other databases. Additional searches were made to provide
context for the politicians who used research.
Results: Major themes identified included: (a) the employment of local estimates of SHS mortality,
(b) linking specific health effects (eg, cancer) to SHS exposure, (c) a focus on the use of research
relevant to bar workers, and (d) the use of research to downgrade the health effects, and attacks
on the credibility of research showing health effects from SHS. Almost half of the 21 Members of
Parliament (MPs), who spoke in parliament about SHS research during 2000–2005, denied or were
sceptical about SHS harm. At least five MPs used tobacco industry funded or disseminated versions
of research. There was some indirect evidence that the degree of exposure to the health sector,
or the tobacco industry and its allies, may have been factors in the use by MPs of the research.
Policy implications: The willingness of some of this group of politicians to adopt tobacco
industry arguments suggests possible options within health promotion. These include the better
enforcement of consumer protection laws (preventing deceptive information by the tobacco
industry and its allies), and the adoption of an increased focus on tobacco industry behaviour within
tobacco control efforts. These moves may have beneficial effects for the use of research in public
health policymaking. The strengthening by the health sector of its advocacy capacity and
effectiveness may also be a crucial step in the better use of research by politicians in the
policymaking process.
Background
Despite the critical nature of the use of law to advance
public health, relatively little is known about the use of
research evidence in the policymaking process for evi-
dence-based health-protecting laws. There is some litera-
ture which suggests that politicians have limited time and
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incentives to absorb research details, and often need to see
an issue at a personal level [1]. The reputation and credi-
bility of research providers is important to politicians, as
is the local relevance [2]. Research may be most influen-
tial in framing policy debates [3,4]. The extent of the
acceptance and use of research may depend on the context
of the 'prevailing narratives', the degree to which there are
political motives for which to contest the research, the
attractiveness of the research in solving community and
political problems, and the clarity of the communication
of the research [2]. That communication requires the sys-
tematic promotion of interaction between researchers and
policymakers,[5,6] in which professional health research
communication and advocacy can be vital [7,8].
However, evidence from Canada indicates that accurate
knowledge by legislators of harm to health from smoking
is related to their declared support for tobacco control
policies [9]. There is some population evidence that the
depth of knowledge and the emotional value of the infor-
mation about smoking's ill-effects is important in decid-
ing consequent decisions [10,11]. For the causes of
chronic diseases in general, there is some evidence that
relevant evidence does not effectively reach policymakers
[12].
Given the critical importance of evidence-based policies
for advancing tobacco control and other aspects of popu-
lation health,[12,13] the considerable obstacles to effec-
tively translating research results to policy,[1] and the
need to better understand upstream obstacles,[14] we
sought to further explore the intersections between
research and policy development. In particular, we exam-
ined the public statements on health research by New Zea-
land parliamentary politicians involved for and against
smokefree policies, during 1997–2005.
International and New Zealand reviews published
between 1986 and 2002 consistently found significant
health risks from SHS (eg,[15,16]). Against this research
consensus, the international tobacco industry has
attempted to create doubt about the strength of this evi-
dence in New Zealand and elsewhere from at least 1981
[17-26]. The industry's efforts included funding of
researchers, whose research then appears far more likely
to conclude that SHS is not harmful [27]. The New Zea-
land context includes the recognition by large majorities
of the public, for over 20 years, that there are at least some
health risks from SHS. Since 1999 this proportion has
been 90% or over,[28] although this recognition may not
include the extent of the serious harm and deaths result-
ing from SHS [29-31].
The New Zealand Smoke-free Environments Act from
1990 required offices, shops and some other workplaces
to be smokefree, but by 1996 about 20% of workers were
still exposed to SHS at work [32]. In 1999, a Private Mem-
ber's Bill was introduced, proposing extended smokefree
workplaces,[33] and it progressed to the Parliamentary
Select Committee in 2000. It was strengthened and passed
in December 2003, with most of the measures imple-
mented in December 2004. Three out of the six political
parties in the Parliament (National, United Future, New
Zealand First) did not impose a party policy for the vote,
and allowed MPs to vote as they wished. In mid 2005, a
Private Member's Bill was introduced by an opposition
MP to reverse some of the smokefree measures, but was
defeated. New Zealand has a unicameral, Westminster
parliamentary system, where members are elected by
mixed-member proportional representation.
The use during 1997–2005 by New Zealand politicians, of
health research evidence about SHS, occurred against a
background of disinformation by the tobacco industry
and its allies. This included statements to the Health
Select Committee of Parliament in November 2002,[34]
and by the Hospitality Association of New Zealand, a
major opponent up to 2004 of the efforts to protect work-
ers from SHS [35,36]. The statements expressed doubt or
denial of the increased risk of cancer and heart disease
from SHS exposure.
Methods
Definition
Research is defined for this article as the systematic collec-
tion and analysis of data.
Data collection
An intrinsic documentary case study was used, in this case,
the study of a group over a limited period, so as to better
understand them and the policymaking process [37-39].
Published and unpublished material recording the use of
research evidence by politicians (about the health effects
from secondhand smoke (SHS) and smokefree policies)
was collected for the period 1997–2005. This included:
media comments; official statements and other official
documents; and parliamentary speeches, questions and
replies. The period 1997–2005 was selected because it
covered the genesis, parliamentary process, and initial
year of implementation of the main part of the Smoke-
free Environments Amendment Act (SFEAA).
A database for the New Zealand Parliamentary Debates was
searched for the period 2000–2005, using the search word
'smoke' [40]. The debates on the proposed law, recorded
in the Parliamentary Debates for the 11 days in which the
Bill was debated during 2000–2003, was read and exam-
ined for uses of research. The Factiva database for news
media[41] was searched for the New Zealand region in the
period 1997–2005, using the search word 'smokefree'Australia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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with either 'parliament' 'minister' or 'government'. Data-
bases for ministerial statements, releases and
speeches[42,43] were searched for the years 1997–2005,
using the search words 'smoke' and 'tobacco'.
To provide context, searches were made in the Parliamen-
tary services database [44], the Factiva database, tobacco
industry document databases, and in the literature on
New Zealand politics.
Data analysis
The data analysis was initially formed by the research
question 'what were the ways in which research evidence
was used by the politicians'. An iterative and inductive
process was used to search for patterns and themes, gener-
ally using constant comparative analysis [45-48]. The
themes were adapted during the reading and rereading of
the material, and the types of themes were discussed by
the three investigators and modified.
To help guard against bias, all references during 2000–
2005 in the Parliamentary Debates (about the health effects
from secondhand smoke (SHS) and smokefree policies)
that were found were used in the analysis. Efforts were
made to ensure that evidence from other sources (eg,
media, official statements) was equally sourced from both
those supporting and rejecting tobacco industry interpre-
tations. Explicit consideration was given to data that went
against the main thrust of the available material, and
efforts were made to ensure that opposing viewpoints
from the data were given when available [48].
Results
We found 89 documents recording the use of research evi-
dence, during 1997–2005, by New Zealand politicians
involved for and against smokefree policies. Sixty eight of
these documents (76%) were from the years 2000, 2001
and 2003, the years when the smokefree places legislation
received the most media and parliamentary attention.
Forty six of the documents were speeches or groups of
speeches in Parliament. Within this material, three major
areas were explored: (i) the use of research evidence about
the health effects from SHS, (ii) who used the research,
and (iii) some of the ways research was used to try and
affect policy.
The use of research evidence about the health effects from 
SHS
Major themes identified in the use of SHS health effects
research included: (a) the use of local estimates of SHS
mortality; (b) linking specific health effects (eg, cancer) to
SHS exposure; (c) a focus on the use of research relevant
to bar workers; and (d) the use of research to downplay
the health effects, and attacks on the credibility of research
showing health effects from SHS. In addition, politicians
used research about the indirect health effects of smoke-
free policies, including the impact on youth smoking
uptake [49].
The use of the Woodward and Laugesen research of 2000
The period 2000–2005 saw the repeated employment of
the research by Woodward and Laugesen on estimates of
mortality in New Zealand from SHS (first published as a
report for government, then as a journal article) [50,51].
In their research, overseas data for disease risks from SHS
was matched with New Zealand data for SHS exposure,
and the rates of deaths in New Zealand by tobacco-attrib-
utable causes. The derived estimate in the report was 388
deaths per year, and in the article 347 deaths per year, in
both cases giving the 'plausible range'. The authors noted:
'Attributable risk estimates provide an indication for
policy makers and health educators of the magnitude
of a health problem; they are not precise predic-
tions'[51].
The Minister of Health stated that:
'The new research indicates some 388 deaths a year are
attributable to second-hand smoke,' that the research:
'confirms the need for stronger measures to protect
people from exposure to second-hand smoke' and
noted that the number killed was: 'about three quar-
ters the number of people killed each year on New
Zealand roads'[52].
Ministers used the mortality research in at least five more
official statements outside of Parliament, supporting the
smokefree legislation change [53-57]. In Parliament, five
MPs used the mortality figures to support smokefree poli-
cies, in eight speeches or replies to questions, [58-65] as
would the Health Select Committee in its report to Parlia-
ment on the draft legislation [66].
Using research on specific health effects and the effects for 
bar workers
After the use of mortality estimates, the most common use
of research was to mention the specific health effects of
SHS exposure. Cancer, heart disease, and stroke were the
diseases normally cited,[49,67-69] but sudden infant
death syndrome (SIDS), asthma, middle ear disease and
respiratory infections were also often mentioned
[49,64,67,68,70,71]. In addition, politicians used
research evidence to argue that smokefree policies would
lead to better health outcomes [72].
Statements by politicians included references to research
on the health risks to bar workers from SHS, and on the
health improvements for bar workers due to smokefree
policies. The statements noted the higher SHS exposure ofAustralia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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bar workers compared to office workers, and higher lung
cancer risks for bar workers compared to the general pop-
ulation [61,67,73,74].
The scepticism about and rejection of health evidence 
about SHS
In doubting or rejecting the health evidence, the argu-
ments included those about the research methods used,
the alleged qualification of SHS risks by the World Health
Organization (WHO), arguments about 'more dangerous'
risks than SHS, and about an alternate 'common sense'
approach. During the Parliamentary debates during 2003
and 2005 on smokefree policies, at least nine MPs from
four different parliamentary parties cast doubt on the evi-
dence of harm to health from SHS – Doug Woolerton and
Dail Jones (New Zealand First), David Carter and Richard
Worth (National), Heather Roy and Deborah Coddington
(ACT) and Peter Dunne, Marc Alexander and Paul Adams
(United Future) [75-85]. Another MP (Winston Peters)
doubted the expertise of those using the research [86]. Bill
English MP minimised the size of the risk [87]. In addi-
tion, Dr Lynda Scott MP indicated some reservations
about the quality of research evidence, but not about the
overall message:
'some of the evidence has been overestimated, but
there is no doubt that second-hand smoke does affect
people'[88].
A number of MPs made efforts to counter this scepticism
or denial [71,89]. Sue Kedgely MP characterised the scep-
ticism or denial by MPs as: 'singing the tobacco industry
tune, that somehow the research is inconclusive'[59].
Attacks on the SHS mortality estimates
During August 2003 – July 2005 there was a substantial
effort by some parliamentary opponents of the legislation
to cast doubt on the Woodward and Laugesen estimates.
At least five MPs made parliamentary speeches in which
varying arguments were made against the use of the esti-
mates. The opponents disagreed with the idea of estimates
being derived from data for disease risks, SHS exposure,
and for rates and numbers of deaths by cause. They asked
for more concrete evidence. David Carter MP asked that
the legislation supporters:
'table the 400 death certificates that have been filed
and state that those people died of secondhand
smoke' and said: 'that member will not be able to table
those death certificates. .... Not one, because they do
not exist. What we see here is a huge manufacturing
and embellishment of the story about the effect of sec-
ond-hand smoke on people's health'[75].
Another concern with the methods used in the mortality
estimate was that there were some unknown variables
involved. An MP (Dail Jones) expressed concerns about
the methods, including the use of previously published
research to establish the disease risks from SHS. He
appeared to expect Woodward and Laugesen to establish
all the data from basic research:
'When people do a research they do it on actual cases.
They do not go searching the literature, which other
people have written, so that they can write about
it'[76].
Doug Woolerton MP was also concerned about the meth-
ods used for the mortality estimates. He stated that 'it is
said that thousands of people are dying in this country
through second-hand smoke',[77] that for the official esti-
mates any death of an ex-smoker is blamed on smoking,
and that such an ex-smoker 'apparently becomes a victim
of secondhand smoke'[77]. Another MP (Heather Roy)
described the methods used for the mortality estimates as
a 'bit of arithmetic, and some heroic assumptions'[78].
Jones further suggested that the work by Woodward/Laug-
esen had been 'discredited by Dr Proctor'[90]. Dr Chris
Proctor, director of science and regulation for British
American Tobacco (BAT), had visited New Zealand in
2001 and 2002,[34,91] and had been reported as saying
that the SHS mortality figures 'could not be proven'[92].
An industry consultant, Peter Lee, had reviewed the
Woodward/Laugesen report for BAT in 2000 [93].
In the arguments about SHS mortality, the statements that
WHO had heavily qualified or denied the risks of SHS
were part of a wider use of this tactic by parliamentary and
other opponents of smokefree laws (detailed further
below). The statements appeared to be based on the idea
that the 1998 study at the International Agency for
Research on Cancer (IARC) on SHS cancer risks had not
shown that there were risks [94]. In fact the study was con-
sistent with other studies in showing that there were such
risks. The international tobacco industry's efforts in creat-
ing and spreading this idea have been described [95].
Deborah Coddington MP stated in 2003 that:
'The World Health Organization has come out and
said that 400 people dying each year from second-
hand smoke is a very dodgy statistic'[79].
She repeated the idea that the estimate was 'dodgy' in
2005 [80]. A further MP (Paul Adams) appeared to want
to put the Woodward and Laugesen SHS mortality esti-
mates into a 'common sense' perspective. This perspective
included Adam's anecdote about his father who hadAustralia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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apparently suffered no adverse consequences of smoking
[81].
Other attacks on research on the health risks of SHS
Beyond the attacks that related to the SHS mortality esti-
mates, other arguments on the health risks included fur-
ther ones about the alleged qualification by the WHO on
SHS risks. There were also arguments about other research
that might suggest that the risks from SHS were not signif-
icant, and about 'more dangerous' risks than SHS. In
2002, the then leader of the Parliamentary Opposition,
Bill English (an ex-Minister of Health), justified his sup-
port for allowing smoking in bars by describing the con-
sequent danger to staff and customers as 'a small health
risk'[87].
The further statements that the WHO had heavily quali-
fied or denied the risks of SHS included those by MPs
Jones and Roy. The latter stated that:
'the effects of second-hand smoke ...are inconclusive.
...a controversial World Health Organization study ...
found ... that non-smokers married to, working with,
or raised with smokers were no more at risk of lung
cancer than anyone else'[78].
This view was reiterated in her minority view in the March
2003 Select Committee Report to Parliament [66]. Dail
Jones MP also misquoted,[90] the WHO Report of 2002
[96]. Contrary to his suggestion that it showed 'no sup-
porting evidence' for harm from SHS, in the section
referred to by Jones (p.66 box 4.1) the report summarises
the respiratory, SIDS, heart, and cancer effects of SHS.
Another MP, Richard Worth, referred to the Enstrom and
Kabat article of 2003 about SHS mortality [97]. This was a
tobacco-industry funded article, where the use and inter-
pretation of the data has been highly disputed [98-104].
Worth said the study:
'has found no significant evidence that second-hand
smoke causes lung cancer or heart disease.' He went on
to quote the article 'The association between passive
smoke, and coronary heart disease and lung cancer,
may be considerably weaker than generally
believed'[82].
Later, Worth stated that, 'I do not accept the health argu-
ments that lie behind this Bill'[82]. Peter Dunne MP also
appears to have cited the 2003 Enstrom and Kabat article
while doubting SHS effects [83].
A final tactic by those sceptical about the validity or rele-
vance of evidence about SHS was to compare other risks
with SHS exposure. Jones stated that:
'Custard is more dangerous than second-hand smoke.
... milk ...is worse than second-hand smoke. ... Bald-
ness is worse than second-hand smoke. ... Those are
the statistics'[90].
Doug Woolerton MP stated:
'This Bill is not based on fact. If it was based on health
...then we would ban motorcars immediately. ... [and
home fires] ... Worldwide those things are the biggest
contaminants of our environment'[84].
Finally, in 2005 Marc Alexander MP argued that if there
was a risk from SHS, why did Parliament not legislate
against other air pollutants?[85].
Who used the research?
During 2000–2005, there were at least 21 MPs speaking in
Parliament who used research or attacks on research to
argue about smokefree policies. This was out of 48 speak-
ers in the parliamentary debates and questions around the
SFEAA, and out of 150 MPs altogether in the two succes-
sive parliaments. Of the 21 MPs, 11 were in support of,
and 10 were against, the smokefree policies (Table 1). In
addition, during 1997–2005 there were at least three MPs
(Delamere, English and Tamihere) who only made state-
ments about the research outside of Parliament.
The background of the MPs who used or attacked the
research varied in the exposure to possible influences,
such as health experience or closeness to the tobacco
industry and its allies. All four MPs from the National,
New Zealand First and United parties who voted for the
smokefree law in 2003 (Paraone, Turner, Hutchinson,
Scott) had been on the Health Select Committee. Hutch-
inson and Scott were medical practitioners, and Paraone
was listed as the director of a 'Maori health com-
pany'[105]. Turner has been a member of a hospital chap-
lains' committee,[105] although she has been reported as
saying 'I have never worked in the health sector. So com-
ing up to speed on health issues and health legislation is
a huge challenge'[106].
Other MPs who spoke about the research also had health
backgrounds. Chadwick has been a nurse, midwife and
health sector manager. King, Dyson, and Turia had health-
related Ministerial positions from 1999 onwards, and
O'Connor and Kedgley had been on the Health Select
Committee [61,105]. Hughes had been an assistant to the
chairperson of the Health Select Committee during 1999–
2002. Roy, the one Health Committee member who
doubted the health effects of SHS in Parliament, had been
a physiotherapist [105].A
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Table 1: Political party affiliations of MPs using or attacking SHS research (in parliamentary speeches or questions 2000–2005) and MP voting patterns in 2003 on extending 
smokefree policies (for MPs on the Health Select Committee during 2000–2003)
MPs using or attacking SHS research Voting pattern by the MPs on the Health Select Committeeb
Partya For Against Total For Against Total
Greens Kedgley 0 1 Kedgley 0 1
Labour Chadwick, Dyson, Hughes, King, O'Connor, Turiac 0 6 Chadwick, Hartley, Hereora, Mahuta, O'Connor, Yates 0 6
NZ First Paraone Jones, Peters, Woolerton 4 Paraone 0 1
United Future Turner Adams, Dunne, Alexander 4 Turner 0 1
National Hutchinson, Scott Carter, Worth 4 Hutchinson, Scott Collins, Sowry 4
ACT 0 Coddington, Roy 2 0 Roy 1
Total 11 10 21 11 3 14
a – Descending order approximately represents the "left to right" political gradient of the political parties.
b – Phillida Bunkle was a member in 2000–2002, but was not re-elected in 2002.
c – Tariana Turia spoke as a Labour Party MP in 2001, but later became a Maori Party MP.Australia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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Worth was the chairman of the law firm Simpson Grier-
son from 1986 to 1999.[105] During 1986–1999, this
firm worked for the Tobacco Institute of New Zealand and
a number of tobacco companies [107-110]. Dunne has
consistently voted against tobacco control legislation, and
his relationship with the tobacco industry has included a
payment to him [111]. Carter has been a hotelier,[105]
and had maintained some links with the Hospitality Asso-
ciation [112]. He was reported to be one of two National
Party MPs in a meeting with seven BAT managers in 2004
[113].
Some of the MPs using or attacking research appear to
have had ideological stances on smoking. Jones was
reported to be an asthmatic who 'within half an hour of
being exposed to cigarette smoke ... would have an asth-
matic attack' but who opposed strengthened smokefree
policies 'because it restricted a person's freedom of
choice'[114]. Woolerton was reported in 2000 as having
personally defied a smoking ban in his parliamentary
office for over six months [115]. He was described in 2004
as remaining 'a passionate advocate of smokers' rights'
even after giving up smoking [116].
How was research evidence used to try to affect policy?
Some indication was found of four ways in which research
evidence was used to try and affect policy. They were: (i)
by helping get policy change onto the political agenda,
(ii) by the exposure of politicians to health professionals
using research, (iii) by repeated exposure of politicians to
a range of evidence, and (iv) by positioning the research
as reliable, 'expert', or 'accepted', and therefore 'preferable'
compared to other types of evidence.
An example of the use of research to get policy change
onto the political agenda occurred in 1997, at a time when
the idea of extending smokefree places policies was being
revived. The new Associate Health Minister, Tuariki Dela-
mere, responded to articles about the health risks of SHS
in the British Medical Journal,[117,118] by suggesting that
smokefree laws for 'restaurants, shopping centres, bars
and indoor public areas should all be looked at'[119].
The exposure of politicians to health professionals, who
combined research evidence and personal testimony, may
have been effective in influencing statements and conse-
quent policy. This possibility occurred most clearly in
Health Select Committee hearings on the proposed law.
Except for three MPs (Roy, Collins and Sowry) all 14 of
the MPs who sat on either of the two successive Health
Committees in 2001–2003 listening to evidence on the
Bill (and were MPs in 2003), voted for the Bill (Table 1).
Pita Paraone gave an indication of the combined effect,
for some, of research and personal submissions.
'It is one thing to be told all these statistics; it is
another thing to witness them in reality. Health pro-
fessionals do so on a daily basis, and that is why one
would be hard-pressed to find a health worker who is
not in favour of limiting the opportunities for smok-
ing and exposure to smoke'[74].
Another MP on the Health Select Committee (Turner)
also indicated that the combination of research evidence
and health professional testimony was persuasive. Her
words also illustrate a precautionary approach to consid-
ering the arguments.
'Regardless of the suspicion that people hang over the
evidence of second-hand smoke being detrimental to
people's health, there is sufficient evidence and back-
ing from medical professions to suggest that those of
us with no medical background need to take heed, and
I plan to do that'[120].
The Associate Minister in change of tobacco control in late
2003, O'Connor, indicated that after initial scepticism,
repeated exposure to research evidence was convincing:
'having sat on the Health Committee for a year .... lis-
tening to submissions from the top to the bottom of
this country, and hearing the evidence, I can say that it
is undeniable and irrefutable that second-hand smoke
kills people in New Zealand'[61].
A further MP (Chadwick) used the experience in the Select
Committee to argue that this gave a greater breadth of
knowledge than was available to New Zealand MPs in
general:
'those of us on the Health Committee – those of us
who had an open mind – heard all the science and all
the reports from around the world, and that gave us
the very clear steer that we [should have] a total
smoke-free environment'[71].
Politician users of research positioned the research as reli-
able, 'expert', or 'accepted', or conversely attacked users of
research as non-expert or unable to understand research.
Sue Kedgley MP stated as part of an argument:
' If the experts are correct, and we can only assume they
are ....'[58] In another speech she stated: 'the truth is
that there is, despite all the efforts to discredit it, over-
whelming medical and scientific consensus that sec-
ond-hand smoke is the leading cause of death and
disease'[59].
Hutchinson defended the source of some of the research
used in the debates, Dr Laugesen, as someone who had:Australia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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'worked extremely hard to ensure that the information
we have in New Zealand is of an absolutely best-prac-
tice, world-class quality, [he had] been published in
international, peer-review papers, and [he had] data
that is very solid indeed'[89].
In attacking the idea of smokefree policies, another MP
(Peters) challenged the use by MPs of research evidence
because they weren't scientists or 'experts'[86]' Con-
versely, Health Minister King portrayed an MP attacking
smokefree policies, Jones, as someone who could not
understand research, as he had:
'been asleep for 20 years, because he does not know
that evidence and science today can link tobacco con-
sumption with cancer, and with other illnesses in New
Zealand and around the world.'
Jones: 'Where is the proof?'
King: 'A man who could deny that is a man who does
not believe in science'[62].
Discussion
Main results
The results suggest two main thematic areas: (i) what
research is effective for political use and why, and (ii) the
issues that arise from tobacco industry efforts to obscure
tobacco-related evidence.
What research works in politics and why
The repeated use of and attacks on the Woodward/Laug-
esen SHS mortality estimates may indicate the importance
of this type of evidence. Research giving a quantified
health impact, particularly numbers of deaths, appears to
be attractive to politicians. While based on disease risk
data from other countries, the research was a way of mak-
ing the New Zealand health impacts more concrete, and
allowing comparisons with other causes of preventable
mortality. Estimates of the numbers of deaths make previ-
ously little-noticed deaths from SHS into a problem com-
parable to road crashes. Similarly, research showing
specific diseases caused by SHS, and specific effects on bar
staff, also enabled politicians to make the harmful
impacts of SHS more concrete.
On the other hand, the figures were seen by some politi-
cians to be vulnerable or inadequate, because of the epi-
demiologic basis for them. Few people can personally
identify any victims of SHS, whereas road crash victims
are named daily by the media. In particular, for the large
proportion of the SHS deaths due to cardiovascular dis-
ease, the victims are not readily identifiable.
Research evidence of SHS health effects is further impor-
tant to politicians, because it helps them support govern-
ment intervention to protect those who can be seen to be
involuntarily affected. It helps in defending against
'nanny-state' accusations. The wide use of research results
about specific health effects indicates that while some sort
of harm from SHS may be taken for granted by the large
majority of New Zealand adults, politicians felt the need
to detail some of the specifics of the harm. Their view is
supported by New Zealand research that indicates that the
public knowledge of the harm from SHS may not be very
deep [29-31].
What tactics and factors work for the tobacco industry
The denial of significant SHS risks, and the attacks by a
group of MPs on the research showing significant risks,
suggests at least two things. Firstly, the tobacco industry
and its allies appear to have been successful in persuading
a proportion of national level politicians that there was
significant doubt about SHS health risks. Secondly, that a
proportion of the politicians can be willing to both pub-
licly disagree with the beliefs of 90% or more of the adult
population,[28] about research results of public health
importance (that there are health risks from SHS), and to
not take a precautionary approach to protect health. We
do not suggest that public opinion is a necessary guide to
good decision making, but it is of concern from a public
health perspective that these politicians did not take this
precautionary approach. The causes of the willingness of
these politicians to go against public opinion in this case
are a question for further research.
Almost half the MPs, who during 2000–2005 spoke in
parliament about SHS research, denied or were sceptical
about SHS harm. There was a general theme, in the attacks
on the research on SHS health effects, that echoed tobacco
industry statements. Why has the tobacco industry been
successful in this way? Well organised and funded indus-
tries have many effective techniques for affecting politi-
cians' ideas [121-125]. The tobacco industry's efforts in
pushing their story on the 1998 IARC report, and in fund-
ing and disseminating the Enstrom and Kabat research,
appear to have paid dividends in New Zealand, with at
least five MPs using that story and research.
Other possible reasons for scepticism and denial include
possible repeated exposure to the tobacco industry or
their allies, being a smoker, and personal or party ideol-
ogy. The 'self-exempting' beliefs (varied forms of denial)
of some smokers about the health risks of smokers may
extend to their stance on smokefree policies [126-128].
Political ideology (including beliefs about the role of gov-
ernment) may help determine politicians' attitudes to
research[9] (eg, as possibly in the case of Jones). A further
possible reason may have been the perception by politi-Australia and New Zealand Health Policy 2007, 4:24 http://www.anzhealthpolicy.com/content/4/1/24
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cians that few of the public might become aware of the
MPs' statements during parliamentary debates.
However, the extent of the industry's success should not
be overstated. It may be that the proportion of New Zea-
land MPs doubting SHS harm is similar to the proportion
in the general population.
Finally, for both those accepting and those sceptical of
research about SHS, a crucial factor in their stance may
have been the degree to which the research was success-
fully presented as a 'story' or series of stories. In this con-
text, a story goes beyond research findings to become
persuasive, through dramatic structure, timing and pres-
entation [129,130]. The story needs to highlight and/or
solve a problem [131]. The 'stories' about SHS, that were
effective for different groups of MPs, clearly differed.
Comments on methods, limitations and further research
The use of electronic databases meant that a large number
of statements by politicians could be readily accessed.
Such documentary case study methods can provide a
means of studying some aspects of health policy that does
not require intensive resources. The use of documents that
were close to first person public statements, or were
recording such statements, limited the possible distortion
of the words and opinions of the politicians concerned.
However, even such statements may need to be treated
with scepticism. Parliamentary speeches may record 'heat
of the moment' opinions, and official statements may
reflect a degree of group consensus that is different from
candid statements from individuals.
The small sample of politicians who spoke about research
means that the results cannot be readily generalised to
New Zealand politicians as a group. However, while this
sample was only 21 out of the 48 (44%) who spoke in
parliament about the smokefree policy proposals, they
may have been more representative of those politicians
who were in key policy development roles within their
parties on smokefree policy issues. The early stage of the
use of a mixed-member proportional system for New Zea-
land parliamentary elections (used since 1996) meant
that the range and membership of the parties in parlia-
ment during 1997–2005 was in constant flux, and thus
not necessarily representative of a longer-term situation
with this type of political system.
Furthermore, the description and selection of themes in
this type of research will to some extent be formed by the
backgrounds of the researchers involved. For instance, an
analysis of the data by those outside the health sector, or
who have not been involved in tobacco control research
to the extent of the authors' involvement (see 'Competing
interests' below), might produce significantly different
themes. The prospects of any such 'neutrality' on tobacco
control policy, and all public policy research, are debated
[132-134].
In-depth interviews of both those who spoke publically
about the research, and those who may have spoken pri-
vately, could reveal much more about the causes for
stances on research by politicians. An analysis of the
words used during other periods of focus on smokefree
policies (such as New Zealand in 1986–1990) could pro-
vide comparisons. Surveys of politicians could provide
more generalisable findings, although adequate response
rates may be difficult to obtain. Studies of the use of sim-
ilar research by politicians in other jurisdictions would
provide valuable comparative data.
Implications for policy and health advocates
The willingness of MPs to adopt tobacco industry argu-
ments in the New Zealand parliament suggests that two
policy initiatives may be productive for protecting public
health. The enforcement of consumer protection laws by
the New Zealand government, preventing deceptive infor-
mation by the tobacco industry and its allies, could reduce
the likelihood of MPs repeating the misinformation. Sec-
ondly, the adoption within tobacco control efforts of an
increased focus on tobacco industry behaviour could have
the consequence of a public better informed about
tobacco industry arguments. In turn, politicians could be
less likely to use the industry's arguments in public. The
options for such an increased focus on tobacco industry
behaviour include effective media campaigns.
More generally, health advocates could consider using
such research findings to enhance the public focus at elec-
tion time on politicians and parties who use tobacco
industry arguments. And, underlying all the efforts to help
improve the effective uptake of research by policymakers,
is the need by the health sector for an increased and highly
skilled advocacy capacity. This is likely to be relevant in
many jurisdictions. Health research 'stories' may need
exceptional storytellers (while still informed by high qual-
ity research) in order to prevail over tobacco industry 'sto-
ries'.
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